Business Context and Reporting Period
This Form 8-K filing by LeMaitre Vascular, Inc. (LMAT) reports on the results of the 2020 Annual Meeting of Stockholders held on July 30, 2020. The company is incorporated in Delaware and its common stock trades on The Nasdaq Global Market.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data.
Material Changes
No material financial changes are reported in this document. The filing details the outcomes of three specific shareholder proposals:
- Election of Directors: Stockholders elected Bridget A. Ross and John A. Roush as Class II directors for three-year terms.
- Executive Compensation: Stockholders approved an advisory vote on executive compensation.
- Accounting Firm Ratification: Stockholders ratified the appointment of Grant Thornton LLP as the independent registered public accounting firm for 2020.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The document is strictly limited to the disclosure of voting results.
Investor Verification Checklist
- Verify the specific vote counts for the election of directors Bridget A. Ross and John A. Roush.
- Confirm the approval status of the advisory vote on executive compensation.
- Validate the ratification of Grant Thornton LLP as the independent auditor for the fiscal year ending December 31, 2020.
- Note that this filing does not contain financial performance data; refer to the most recent 10-K or 10-Q for financial metrics.